European Stocks Advance, Led by ABN Amro, Barclays, BT Group, Glaxo

(Bloomberg) -- European stocks rose for a third day,
led by ABN Amro Holding NV after Royal Bank of Scotland Group Plc
sweetened its 71.1 billion-euro ($98.1 billion) offer for the
Dutch lender, seeking to trump Barclays Plc.

ABN Amro jumped the most in three months. Barclays also
climbed. BT Group Plc, the U.K.'s largest phone company, and
drugmaker GlaxoSmithKline Plc rose after brokerages lifted their
recommendations on the shares.


Read more at Bloomberg Stocks News

European Stocks Advance, Led by ABN Amro, Barclays, RBS, BT Group

(Bloomberg) -- European stocks rose for a third day,
led by ABN Amro Holding NV after Royal Bank of Scotland Group Plc
sweetened its 71.1 billion-euro ($98.1 billion) offer for the
Dutch lender, seeking to trump Barclays Plc.

Barclays also climbed. BT Group Plc advanced after Merrill
Lynch & Co. upgraded the stock.


Read more at Bloomberg Stocks News

BT Group Returns to Bond Market After 6 Years With 1.5 Billion-Pound Sale

(Bloomberg) -- BT Group Plc, the U.K.'s largest
phone company, sold the equivalent of 1.56 billion pounds ($3.07
billion) of bonds in pounds and euros, according to a banker
managing the sale who declined to be named.

The sale by London-based BT was in three parts and is the
company's first debt issue in more than six years, according to
data compiled by Bloomberg.


Read more at Bloomberg Bonds News

JGB slide deepens on Treasury sell-off

(Reuters) - December euroyen futures fell as much as 3.5 basis
points to 98.945, a 10-year low. June JGB futures tumbled 0.65
point to 131.60 , an 11-month trough. The five-year yield
struck an all-time high of 1.520 percent, also up 6
basis points.




Read more at Reuters.com Bonds News

Dendreon, Digene, Flextronics, Sirius, Solectron: U.S. Equity Preview

(Bloomberg) -- The following is a list of companies
whose shares may have unusual price changes in U.S. exchanges
today. This preview includes news that broke after exchanges
closed June 1. Stock symbols are in parentheses after company
names. Share prices are as of 9:10 a.m. New York time.

Abbott Laboratories (ABT US) fell 75 cents, or 1.3 percent,
to $55.55 in trading before of U.S. exchanges. Shares of the
drugmaker may fall to $48 as questions about the safety of its
TriCor cholesterol drug rise, Barron's said, without citing
anyone. Abbott stock fell 5 cents to $56.30. ``There is
absolutely no data to substantiate any change to the safety and
efficacy of TriCor,'' Laureen Cassidy, a spokeswoman for Abbott,
told Bloomberg News.


Read more at Bloomberg Stocks News

Abbott Labs, Onyx Pharmaceuticals, Sirius, Solectron: U.S. Equity Preview

(Bloomberg) -- The following is a list of companies
whose shares may have unusual price changes in U.S. exchanges
today. This preview includes news that broke after exchanges
closed June 1. Stock symbols are in parentheses after company
names. Share prices are as of 8:10 a.m. New York time.

Abbott Laboratories (ABT US): Shares of the drugmaker may
fall to $48 as questions about the safety of its TriCor
cholesterol drug rise, Barron's said, without citing anyone.
Abbott stock fell 5 cents to $56.30. ``There is absolutely no
data to substantiate any change to the safety and efficacy of
TriCor,'' Laureen Cassidy, a spokeswoman for Abbott, told
Bloomberg News. Shares fell 5 cents to $56.30 in regular trading
yesterday.


Read more at Bloomberg Stocks News